15 Drugs Approved for Primary Care in 2022

With 2022 at an end, Patient Care Online has compiled a list of key drugs approved by the US Food and Drug Administration (FDA) for conditions that are often seen in primary care. Scroll through the slides below to find details on a new oral solution of amlodipine; the first and only FDA-approved, once-daily amphetamine transdermal patch for the treatment of attention deficit hyperactivity disorder; the first and only specific interleukin-23 inhibitor to be approved for the treatment of Crohn disease in adults; the first drug indicated for the treatment for eosinophilic esophagitis; a novel rapid-acting treatment for major depressive disorder; and 10 more.